The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, the plasma was leaking out of the exhaust port.As per user facility, the patient is scheduled for bilateral orthotopic lung transplantation.They did not change out the product but they turned up the gas flow and turned off the fio2 setting.The patient has a body surface area (bsa) of 1.92m2, had 1200ml of plasmalyte, 600ml of blood and 250ml of colloid(alb).*no known impact or consequence to patient.*the surgery was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on november 19, 2019.Upon further investigation of the reported event, the following information is new and/or changed: (identification of evaluation codes 10, 38, 3331, 4210, 4307).Method code #1: 11 testing of device from same lot/batch retained by manufacturer.Method code #2: 3331 analysis of production records.Method code #3: 4114 device not returned.Results code: 4210 leakage/seal.Conclusions code: 4315 cause not established.The affected sample was inspected upon receipt with fluid observed in the chamber, no other anomalies were noted.The affected sample was thoroughly rinsed and dried.The sample was setup for mechanical integrity testing, leakage was observed at 150mmhg of pressure.The unit was thoroughly dried again.Once dry, the unit was circulated with bovine blood at the pump record conditions (pressure, hematocrit, etc) with nitrogen flowing through the gas side.The unit leaked plasma shortly after starting circulation.The unit was then dyed with rhodamine and dissected.Analysis with a sem showed no anomalies.Ftir analysis showed protein remnants.The appropriate retention sample was tested for gas transfer ability at zero time and following a six hour blood circulation.Blood flow for testing and circulation was set to 8 l/min.The plasma leakage event was confirmed through provided pictures and through observation of the affected sample during a circulation of bovine blood.Significant evaluation was conducted to determine the potential cause of the reported event.The retention unit was subjected to gas transfer testing before and after a six hour circulation period.With no significant observations made.It's possible that patient/clinical conditions may have contributed to the issue.Therefore, an exact cause of the plasma leakage could not be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|